Apogee Therapeutics
Aneta Liwosz is a seasoned professional in analytical development and quality control, currently serving as Director at Apogee Therapeutics since November 2023. Prior experience includes a Fellow position at Mersana Therapeutics from December 2018 to October 2023, where Aneta managed CROs, CMOs, and analytical outsourcing labs while supervising a team of research associates and scientists. Aneta also held roles as Principal Scientist and Senior Scientist at Momenta Pharmaceuticals from July 2012 to November 2018, and as a Scientist in Analytical Development at Percivia from September 2006 to April 2012, where Aneta focused on protein characterization. Aneta began a career in research as a Postdoctoral Research Fellow at Boston University School of Medicine from January 2003 to September 2006, following a Ph.D. in Biochemistry from the Institute of Biochemistry and Biophysics Polish Academy of Sciences.
This person is not in any teams
This person is not in any offices
Apogee Therapeutics
1 followers
Apogee Therapeutics, Inc. is a biotechnology company advancing novel therapies to address patients’ needs. Based in San Francisco and backed by leading life sciences funds, the company expects its lead pipeline program to enter clinical trials in 2023.